Skip to content
Subscriber Only
Business
Prognosis

BioNTech Sees Potential to Supply 3 Billion Doses in 2022

  • CEO Sahin says lifting vaccine production depends on demand
  • Company already in discussion about Covid booster shots
Video player cover image
BioNTech Could Supply 3 Billion Covid Shots in 2022: CEO
Updated on

Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.

BioNTech SE could have capacity to make 3 billion doses of Covid-19 vaccine with U.S. partner Pfizer Inc. next year, the German company’s chief executive officer said, making their pioneering shot far more widely available around the world.